Health product recall

Cipla Omnigel Spray: Unauthorized product

Last updated

Summary

Product
Cipla Omnigel Spray
Issue
Health products - Unauthorized product
What to do

Consult your health care professional if you have any health concerns.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

Cipla Omnigel Spray

Cipla Omnigel Spray

Unauthorized

Spray

Dicofenac Diethylamine 1.16% w/w,
Methyl salicylate 10% w/w

OMG23054

Issue

Prescription drug sold without market authorization (DIN) in Canada. The product is labelled to contain diclofenac diethylamine that is listed on the prescription drug list.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Shivani Sales Inc.

976 Powell Ave., Winnipeg, MB R3H 0H6

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-75770

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe